4月17日 - ** 糖尿病设备制造商股价盘前下跌1%至3
** 礼来LLY.N称， (link)，在一项后期试验中，其口服药物orforglipron使超重的2型糖尿病患者的体重平均减轻了7.9%，血糖也有所降低。
** 生产连续血糖监测仪的DexcomDXCM.O股价盘前下跌2.6%，报66.94美元。
** 胰岛素泵制造商Tandem Diabetes Care TNDM.O和Insulet Corp PODD.O的股价分别下跌约2%。
** LLY股价盘前上涨13.4%至833.56美元
** 截至上一交易日收盘，DXCM下跌11.6%，TNDM下跌52.1%，LLY下跌4.8%，PODD下跌4%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.